New Drug Could Change Lives of Kids with Resistant Epilepsy, Patient Trials Concluded The trial involved 81 children between the ages of 2 and 18 that suffered up to 18 seizures a month resulting from Dravet syndrome

#Zorevunersen, shows that pharmaceuticals can work to improve the lives of patients with these #epilepsies

#UK drug trials in phase 2 clinical trials now.

Drug breakthrough for children with rare form of extreme epilepsy Families say the groundbreaking medicine is transforming the lives of children with Dravet syndrome.

Promising results of reduced #seizure frequency from early-phase trials of the antisense oligonucleotide #zorevunersen, administered via a spinal infusion in children with #Dravet syndrome:
www.bbc.co.uk/news/article...

Case builds for Biogen, Stoke's Dravet syndrome drug Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen

#Biogen #Dravetsyndrome #childhoodepilepsy #StokeTherapeutics #zorevunersen #EMPERORtrial #antisenseoligonucleotide #ASO #SCN1Agenemutation #EPNS #Developmentalencephalopathy #epilepticencephalopathy #Dravetsyndromepatients #SUDEP #paediatricneurology
pharmaphorum.com/news/case-bu...